Endothelial nitric oxide synthase: From structure to function in one aspartic substitution

Kidney International

Volumn 75, Issue 3, 2009, Pages 255-257

  Goligorsky, Michael S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

AMINO ACID SUBSTITUTION; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL ADHESION; CELL MIGRATION; DNA POLYMORPHISM; ENDOTHELIAL DYSFUNCTION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; NOTE; PHENOTYPE; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 58349116701     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.605     Document Type: Note

References (11)

1. Cooke G, Doshi A, Binkley P. Endothelial nitric oxide synthase gene: prospects for treatment of heart disease. Pharmacogenomics 2007; 8: 1723-1 734.
2. Casas J, Bautista L, Humphries S et al. Endothelial nitric oxide synthase genotype and ischemic heart disease. Meta-analysis of 26 studies involving 23028 subjects. Circulation 2004; 109: 1359-1365.
3. Cehrney DZI, Scholey JW, Zhou J et al. Endothelial nitric oxide synthase gene polymorphisms and the renal hemodynamic response to L-arginine. Kidney Int 2009; 75: 327-332.
4. Tsukahara H, Gordienko D, Goligorsky MS. Continuous monitoring of NO release by endothelial cells. Biochem Biophys Res Commun 1993; 193: 722-729.
5. Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006; 113: 1708-1714.
6. Mount P, Kemp B, Rower D. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 2007; 42: 271-279.
7. Joshi M, Ferguson B, Johnson F et al. Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells. Proc Natl Acad Sci USA 2007; 104: 9982-9987.
8. Tesauro M, Thompson W, Rogliani P et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 2000; 97: 2832-2835.
9. Fairchild T, Fulton D, Fontana J et al. Acidic hydrolysis as a molecular mechanism for the cleavage of the Glu298 → Asp variant of human endothelial nitric oxide synthase. J Biol Chem 2001; 276: 26674-26679.
10. Joshi M, Mineo C, Shaul P et al. Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J 2007; 21: 2655-2663.
11. Salerno J, Harris D, Irizarry K et al. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J Biol Chem 1997; 272: 29769-29777.